Missing/wrong data?
Log in to edit
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.
scientific article
Author/s
author: Kelsey Loeliger, Phillip Scheinberg
Work details
Publication date
November 1, 2010
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.